Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response

Cited by (296)

Items 201–296 of 296

  1. Superoxide Anion Generation, Its Pathological Cellular and Molecular Roles and Pharmacological Targeting in Inflammatory Pain: Lessons from the Potassium Superoxide Model
    Beatriz H. S. Bianchini, Geovana Martelossi-Cebinelli, Jessica Aparecida Carneiro, Fernanda Soares Rasquel-Oliveira, Rúbia Casagrande, Waldiceu Aparecido Verri Jr · 2025 · Future Pharmacology
  2. Identification of novel Nrf2/Keap1 pathway mutations in pediatric acute lymphoblastic leukemia
    Dilara Fatma Akın, Sedef Hande Aktaş, Mehmet Altay Ünal, Teoman Kankılıç · 2019 · Pediatric Hematology and Oncology
  3. Nrf2 Activation Ameliorates Hepatotoxicity Induced by a Heme Synthesis Inhibitor
    Keiko Taguchi, Saho Masui, Tohru Itoh, Atsushi Miyajima, Masayuki P. Yamamoto · 2018 · Toxicological Sciences
  4. The dynamic equilibrium between the protective and toxic effects of matrine in the development of liver injury: a systematic review and meta-analysis
    Weiyi Feng, Te-chan Kao, Jiajie Jiang, Xinyu Zeng, Shuang Chen, Jinhao Zeng, Yu Chen, Xiao Ma · 2024 · Frontiers in Pharmacology
  5. The crosstalk between Nrf2 and pyroptosis in diseases
    Xiaomei Wang, Marzieh Monemi, Fatemeh Mortazavi Moghadam, Ahmad Fazilat, Salomeh Roshani, Mohammad Valilo · 2025 · Pathology - Research and Practice
  6. Cistanche flavonoids activate the Keap1-Nrf2-ARE signaling pathway in improving cognitive dysfunction in Alzheimer's disease: A review
    Ruiqi Zhao, Wanfu Bai, Zhenyu Tian, Xinye Li, Ruijun Sun, Ziqi Wang, Xusheng Yan, Jianxin Jia · 2025 · Journal of Alzheimer s Disease
  7. NRF2 activation in cancer and overview of NRF2 small molecule inhibitors
    Hoang Hai Ngo, Bo-Yeong Yu, Jeong‐Eun Lee, Hyun Woo Kim, Young‐Sam Keum · 2025 · Archives of Pharmacal Research
  8. Systemic activation of NRF2 contributes to the therapeutic efficacy of clinically-approved KRAS-G12C anti-cancer drugs
    Liam Baird, Lin Zhang, Takanori Hidaka, Lyu Xi, Ke Wang, Keiko Tateno, Tatsuro Iso, Takafumi Suzuki, Kazuki Kumada, Fumiki Katsuoka et al. · 2025 · British Journal of Cancer
  9. Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients
    Alessandro Allegra, Giuseppe Murdaca, Giuseppe Mirabile, Sebastiano Gangemi · 2023 · Biomedicines
  10. Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction
    Xiaoning Gao, Wuyan Guo, Peiyuan Liu, Mingyue Yuwen, Hongyu Ren, Shengtao Hu, Zixiang Liu, Ruyang Tan, Kairui Liu, Zhiru Yang et al. · 2026 · eLife
  11. Glutathione Transferases
    Bengt Mannervik, Ralf Morgenstern · 2024 · Elsevier eBooks
  12. The effects of phenolic acid supplementation on intestinal barrier function: a review
    Li Xia, Xiulian Lin, Yuanjiao Zhou, Yamei Li, Yingyan Liao, Yan Lin, Limei Lin, Ping Wu, Jingchen Xie · 2025 · Food & Function
  13. The role of Nrf2 in autoimmunity and infectious disease: Therapeutic possibilities
    Robert Arthur Freeborn, Cheryl Elizabeth Rockwell · 2021 · Advances in pharmacology
  14. Patenting perspective on Keap1 inhibitors (2019–2024)
    Yongfu Luo, Wenlong Yang, Yuan Zhang, Shutong Jiang, Jingyu Zhu, Xiangyang Li, Qidong You, Mengchen Lu · 2025 · Expert Opinion on Therapeutic Patents
  15. A Comprehensive Review on the Metabolic Cooperation Role of Nuclear Factor E2-Related Factor 2 and Fibroblast Growth Factor 21 against Homeostasis Changes in Diabetes
    Bahar Kiani, Sahar Yarahmadi, Mohsen Nabi‐Afjadi, Hanie Eskandari, Maryam Hasani, Zahra Abbasian, Elham Bahreini · 2022 · Clinical Diabetology
  16. Sex-based differences in the NRF2 oxidative stress response: Implications for precision therapeutics
    Giusy Russomanno, Karolina Kwiatkowska, Ian M. Copple · 2026 · Redox Biology
  17. The alleviative effect of flavonol‐type Nrf2 activator rhamnazin from Physalis alkekengi L. var. franchetii (Mast.) Makino on pulmonary disorders
    Xueyi Wu, Tian Wang, Hui‐Xin Hu, Kan Zhang, Yu Zhao, Baobing Zhao, Hong‐Xiang Lou, Xiao‐Ning Wang, Tao Shen · 2022 · Phytotherapy Research
  18. Free Radical Research in Cancer
    Ana Čipak Gašparović · 2020 · MDPI eBooks
  19. Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson’s disease
    Monisha Arumugam, Ranjith Sanjeeve Pachamuthu, Emdormi Rymbai, Aditya Prakash Jha, Kalirajan Rajagopal, Ram Kothandan, Santhoshkumar Muthu, Divakar Selvaraj · 2024 · Molecular Diversity
  20. The KEAP1-NRF2 system and neurodegenerative diseases
    Akira Uruno, Masayuki P. Yamamoto · 2023 · Antioxidants and Redox Signaling
  21. Cytoprotective Effect of Pteryxin on Insulinoma MIN6 Cells Due to Antioxidant Enzymes Expression via Nrf2/ARE Activation
    Junsei Taira, Ryuji Tsuda, Chika Miyagi‐Shiohira, Hirofumi Noguchi, Takayuki Ogi · 2023 · Antioxidants
  22. Dual targeting of Keap1 and Gsk-3 by hexaraphane in the regulation of transcription factor Nrf2
    Ángel J. García‐Yagüe, Eduardo Jose Cueto-Diaz, Maribel Escoll, Isao Okunishi, John D. Hayes, Marı́a Isabel Rodrı́guez-Franco, Ana Isabel Rojo, Antonio Cuadrado · 2025 · Free Radical Biology and Medicine
  23. Therapeutic potential of isothiocyanates by targeting the NRF2 pathway
    Ángel J. García‐Yagüe, Eduardo Cazalla, Antonio Cuadrado · 2026 · Free Radical Biology and Medicine
  24. Long-term 1,2-dimethylhydrazine triggers pathological remodeling of colon mucosa through repression of sestrin2, nuclear factor (erythroid-derived 2)-like 2, and sirtuin4 stimulating mitochondrial stress and metabolic reprogramming
    Bader-Edine Allal, Abdelkader Bounaama, Dany Silva, Clara Quintas, Salim Ismail Dahlouk, Jorge Gonçalves, Bahia Djerdjouri · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
  25. Heat stress induces oxidative stress and activates the KEAP1‐NFE2L2‐ARE pathway in reproduction‐related cells
    Hanako Bai, Manabu Kawahara, Kazuya Kusama, Toshihiro Sakurai, Christiane D. Pfarrer, Masashi Takahashi · 2025 · Animal Science Journal
  26. Effects of fatty acid nitroalkanes on signal transduction pathways and airway macrophage activation
    Melissa L. Wilkinson, Andrew J. Gow · 2021 · Innate Immunity
  27. Urinary Thioredoxin as a Biomarker of Renal Redox Dysregulation and a Companion Diagnostic to Identify Responders to Redox-Modulating Therapeutics
    Kenji Kasuno, Junji Yodoi, Masayuki Iwano · 2021 · Antioxidants and Redox Signaling
  28. Innate Immune Recognition Molecules
    Walter Gottlieb Land · 2018 · Springer eBooks
  29. Effects of Inhibition of IKK Kinase Phosphorylation On the Cellular Defence System and HSP90 Activity
    Miriam Giacomarra, Martina La Torre, Giovanna Montana · 2023 · Inflammation
  30. Cell-Autonomous (Cell-Intrinsic) Stress Responses
    Walter Gottlieb Land · 2018 · Springer eBooks
  31. NRF2 and paraquat-induced fatal redox stress
    Jiaojiao Pang, Ying Zhang, Shuyi Wang, Qi Han, Ruru Sun, Changchang Xu, Yue Zheng, Feng Xu, Yuguo Chen, Jun Tao Ren · 2020 · Elsevier eBooks
  32. Atherosclerosis
    Walter Gottlieb Land · 2020 · Springer eBooks
  33. The Chemopreventive Power of Isothiocyanates
    Sharadha Dayalan Naidu, Lidia Brodziak‐Jarosz, Clarissa Gerhäuser, Albena T. Dinkova‐Kostova · 2020 · Springer eBooks
  34. KEAP1/NRF2 as a druggable target
    Albena T. Dinkova‐Kostova · 2023 · Arhiv za farmaciju
  35. Platelet‐Released Growth Factors (PRGFs) Activate NRF2‐ARE and Modulate Inflammatory Response in an NRF2‐Dependent Manner in Primary Human Keratinocytes
    Matthias Stein, Nicole Böttcher, Mersedeh Tohidnezhad, Athanassios Fragoulis, Andreas U. Bayer, Hannes Klump, Jens Malte Baron, Thomas Pufe · 2025 · Journal of Cosmetic Dermatology
  36. KMN003 activates Nrf2 via disruption of the Keap1-Nrf2 interaction and p38-dependent transcriptional regulation
    Keijiro Komeda, Kai Toyoshima, Daisuke Yasuda, Hanako Ishida, Koujin Kojima, Masanori Osawa, Tomoya Hirano, Tomoyuki Ohe, Kenji Tago, Megumi Funakoshi‐Tago · 2025 · Cellular Signalling
  37. Targeting NRF2 With Isoeugenol: A Promising Small Molecule for Neurodegenerative, Metabolic, and Chronic Inflammatory Disorders
    Ana Silva, Sónia Silva, Beatriz Rodrigues, Gonçalo Simões, Inês Dinis, Mafalda Freitas, Rosa Resende, Joana Bicker, Ana C. Fortuna, Maria M. Silva et al. · 2025 · Oxidative Medicine and Cellular Longevity
  38. Altered transposon element-derived genes distort oxygen-free radical scavenger systems in FXD
    Tamaki Suganuma, Huzaifa Hassan, Selene Swanson, Sunil Laxman, Jerry L. Workman · 2026 · NAR Molecular Medicine
  39. Allosecurinine Derivative with Two Michael Acceptors Activates Keap1-Nrf2 Pathway
    Seoyoung Kim, Rium Kim, Taejin Chu, Jong-Hyun Park, Ki Duk Park, Sunkyu Han · 2026 · Journal of Agricultural and Food Chemistry
  40. Targeting NRF2 addiction in cancer: synthetic lethal strategies beyond direct inhibition
    Melat T. Gebru, David Stokoe · 2026 · Frontiers in Cell and Developmental Biology
  41. Monoterpene-rich essential oils as natural NRF2 activators: Chemistry, mechanism and antioxidant effects
    Melford Chuka Egbujor, Sankhadip Bose · 2026 · Letters in Drug Design & Discovery
  42. The Cytoprotective Activity of Nrf2 Is Regulated by Phytochemicals (Sulforaphane, Curcumin, and Silymarin)
    Nancy Vargas-Mendoza, Eli Mireya Sandoval-Gallegos, Eduardo Madrigal‐Santillán, Mauricio Morales-Martínez, Marvin Antonio Soriano-Ursua, Marcelo Ángeles-Valencia, Ángel Morales‐González, Jacqueline Portillo-Reyes, José A. Morales‐González · 2021 · Reference series in phytochemistry
  43. Nrf2 as a potential target for improving wound healing in the elderly
    Tetiana R. Dmytriv, Oleh V. Lushchak, Volodymyr I. Lushchak · 2024 · Advances in biogerontology
  44. Considerations for antibody-based detection of NRF2 in human cells
    Alicja Dziadosz, Sara Mikac, Artur Piróg, Zuzanna Urban‐Wójciuk, Monikaben Padariya, Umesh Kalathiya, Sachin Kote, Alicja Sznarkowska · 2025 · Redox Biology
  45. Basal activation of astrocytic Nrf2 in neuronal culture media: Challenges and implications for neuron-astrocyte modelling
    Mohamed Moftah Omer Elsharkasi, Beatrice Villani, Geoffrey Wells, Fiona Kerr · 2025 · Brain and Neuroscience Advances
  46. Quantum chemical studies and pharmacophore modeling for designing novel keap1 antagonists that enhance nrf2 mediated neuroprotection
    FNU Srinidhi · 2021 · African Journal of Biological Sciences
  47. Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction
    Xiaoning Gao, Wuyan Guo, Peiyuan Liu, Mingyue Yuwen, Hongyu Ren, Shengtao Hu, Zixiang Liu, Ruyang Tan, Kairui Liu, Zhiru Yang et al. · 2024 · eLife
  48. Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction
    Xiaoning Gao, Wuyan Guo, Peiyuan Liu, Mingyue Yuwen, Zixiang Liu, Ruyang Tan, Kairui Liu, Zhiru Yang, Junli Ba, Xue Tao Bai et al. · 2025 · eLife
  49. The Ancestral KEAP1-NRF Pathway in Amphioxus Branchiostoma japonicum: Implications for the Evolution of Antioxidant Defense System
    Weichen Li, Xiaoqian Liang, Keyu Xiang, Hongyan Li, Yu Zhang · 2025 · International Journal of Molecular Sciences
  50. Nrf2 contributes to the protective effect of iron overload on thioacetamide-induced chronic liver injury in rats
    Nanako Hamada, Yuri Ito, Hinata Niimi, Machi Atarashi, Mitsuru Kuwamura, Keiko Taguchi, Masayuki Yamamoto, Takeshi Izawa · 2025 · Toxicological Sciences
  51. Artemisinin sensitizes triple negative breast cancer to immune checkpoint therapy through suppressing KEAP1-mediated PD-L1 degradation
    Zehua He, Zhaoshuai Chen, Lei Wang, Ziyi Hu, Zhixin Wang, Jiehang Zhou, Yiran Zhu, Zhaorui Lyu, Wencan Zhang, Fan Lin et al. · 2026 · Biochemical Pharmacology
  52. Methylglyoxal: Hijack-to-survive paradigm of cancer progression
    Mansi D. Patel, Sudhir Kumar Rawal, Samson Mani · 2026 · Gene Reports
  53. Dietary Polyphenols as Modulators of Redox Signalling: From the Antioxidant-Pro-Oxidant Continuum to Clinical Translation (2015–2025)
    José Manuel Pérez de la Lastra, Celia María Curieses Andrés, Elena Bustamante Munguira, Celia Andrés, Eduardo Pérez Lebeña · 2026 · Current Issues in Molecular Biology
  54. Discovery and Development of Keap1-Nrf2 Protein-Protein Interaction Inhibitors
    Zhengyu Jiang, Qidong You · 2018 · Springer eBooks
  55. Interactions of Cadmium with Signaling Molecules
    Douglas M. Templeton, Ying Liu · 2018 · Springer eBooks
  56. The Cytoprotective Activity of Nrf2 Is Regulated by Phytochemicals (Sulforaphane, Curcumin, and Silymarin)
    Nancy Vargas-Mendoza, Eli Mireya Sandoval-Gallegos, Eduardo Madrigal‐Santillán, Mauricio Morales-Martínez, Marvin Antonio Soriano-Ursua, Marcelo Ángeles-Valencia, Ángel Morales‐González, Jacqueline Portillo-Reyes, José A. Morales‐González · 2022 · Reference series in phytochemistry
  57. The Growing Clinical Relevance of Cellular Stress Responses and Regulated Cell Death
    Walter Gottlieb Land · 2020 · Springer eBooks
  58. Cadmium: Biomolecular Interactions
    Douglas M. Templeton · 2023 · Wiley eBooks
  59. Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction
    Xiaoning Gao, Wuyan Guo, Peiyuan Liu, Mingyue Yuwen, Zixiang Liu, Ruyang Tan, Kairui Liu, Zhiru Yang, Junli Ba, Xue Tao Bai et al. · 2024 · eLife
  60. Genetic Variations in Nrf2-Keap1 Complex: A Step towards Understanding Cancer Resistance in Blind Mole Rats Cytotypes
    Dilara Fatma Akın, Teoman Kankılıç · 2019 · Biology Bulletin
  61. Nrf2 in the Regulation of Endothelial Cell Homeostasis During Inflammation
    Hiromi Yamazaki, Ken Itoh · 2020 · Progress in inflammation research
  62. FAIR and bias-free network modules for mechanism-based disease redefinitions
    Ahmed Hassan · 2021 · Research Publications (Maastricht University)
  63. Quantum Chemical Studies and Pharmacophore Modeling for Designing Novel Keap1 Antagonists that Enhance Nrf2 Mediated Neuroprotection
    FNU Srinidhi · 2020 · ChemRxiv
  64. Faculty Opinions recommendation of Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants.
    Stuart A. Lipton · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  65. Quantum Chemical Studies and Pharmacophore Modeling for Designing Novel Keap1 Antagonists that Enhance Nrf2 Mediated Neuroprotection
    FNU Srinidhi · 2020 · ChemRxiv
  66. Role of oxygen on Nuclear factor erythroid-2-like 1 (NFE2L1 or Nrf1) function and stability
    Haiyun Bo · 2019
  67. Quantum Chemical Studies and Pharmacophore Modeling for Designing Novel Keap1 Antagonists that Enhance Nrf2 Mediated Neuroprotection
    FNU Srinidhi · 2020 · ChemRxiv
  68. Quantum Chemical Studies and Pharmacophore Modeling for Designing Novel Keap1 Antagonists that Enhance Nrf2 Mediated Neuroprotection
    FNU Srinidhi · 2020 · ChemRxiv
  69. Quantum Chemical Studies and Pharmacophore Modeling for Designing Novel Keap1 Antagonists that Enhance Nrf2 Mediated Neuroprotection
    FNU Srinidhi · 2020 · ChemRxiv
  70. The implications of oxidative stress in long COVID pathogenesis
    Vesna M. Coric · 2023 · Medicinski podmladak
  71. Chitosan Oligosaccharide Alleviates Diabetic Nephropathy by Strengthening Intestinal Barriers Via Suppressing Myosin Light Chain Kinase and Renal Fibrosis in Type 2 Diabetic Rats
    Prempree Sutthasupha, Sasivimon Promsan, Nattavadee Pengrattanachot, Nichakorn Phengpol, Chorchat Lalichatsakul, Laongdao Thongnak, Krit Jaikumkao, Rath Pichyangkura, Chatchai Muanprasat, Anusorn Lungkaphin · 2024 · SSRN Electronic Journal
  72. Identification of Keap1a and Keap1b in Grass Carp (Ctenopharyngodon Idellus) and Response of Keap1-Nrf2 Signaling Pathway to Heat Stress Oxidative Stress
    Jingjing Feng, Hua Liu, Ying Yang, Hui Yu, Meiling Yang, Manting Tian, Mingjian Lai, Yali Wu, Aimei Du · 2025 · SSRN Electronic Journal
  73. Potential of diterpenoid andrographolide in COVID-19 therapy: an insight on its antiviral-, immunomodulatory-, anti-inflammatory-, antioxidant- and antithrombotic- properties
    Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, Bishu Karmakar · 2025 · Phytomedicine Plus
  74. Hexaraphane as a potential therapeutic strategy for tauopathies
    Ángel J. García‐Yagüe, Daniel Carnicero-Senabre, Ángel Núñez, Raffaela Cipriani, Estibaliz Capetillo‐Zarate, Maribel Escoll, Isao Okunishi, Ana Isabel Rojo, Antonio Cuadrado · 2026 · Redox Biology
  75. The antioxidant transcription factor NRF2 as a new regulator of the extracellular matrix in human skin fibroblasts
    Mélanie Salamito · 2020 · theses.fr (ABES)
  76. A Hetero-multivalent Covalent Strategy for Enhanced Pulmonary Fibrosis Therapy
    Guang‐Bo Ge, Guanghao Zhu, Yanyan Deng, Haonan Wu, Huaibo Zhang, Guang Zhu, Hairong Zeng, Nan Li, Lixin Wang, Yufan Fan et al. · 2026 · Research Square
  77. Capsaicin acts as a novel NRF2 agonist to suppress ethanol induced gastric mucosa oxidative damage by directly disrupting the KEAP1-NRF2 interaction
    Xiaoning Gao, Wuyan Guo, Peiyuan Liu, Mingyue Yuwen, Hongyu Ren, Shengtao Hu, Zixiang Liu, Ruyang Tan, Kairui Liu, Zhiru Yang et al. · 2026 · eLife
  78. Compensation for impaired sensing of selenoprotein deficiency by alternative cysteine residues in KEAP1
    Miu Sato, Takuya Iijima, Takafumi Suzuki, Masayuki P. Yamamoto · 2026 · Redox Biology
  79. Beyond KEAP1: The Context-Specific NRF2 Partner Code in Disease and Therapy
    Seung-Jin Kwag, Jin‐Kwon Lee, Seung-Jun Lee, Jae-Min Hwang, Young‐Sool Hah · 2026 · Antioxidants
  80. Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy
    Joseph Carmicheal, Caden Fritson, Alexandra A. Seas, Heidi M. Vieira, Surinder K. Batra · 2026 · Cancer Medicine
  81. TrxR Inhibition and Nrf2–FOXO3 Modulation by Repurposed Drugs: A Redox Strategy to Reverse Cancer Multidrug Resistance
    Charan Singh Pawar, Nagarajan Rajendra Prasad · 2026 · Drug Development Research
  82. Inter-domain distance analysis reveals conformational changes in the Keap1-Nrf2 stress sensor system
    Ritsumi Saito, Takeshi Kawabata, Seisuke Yamashita, Keisuke Oki, Takashi Fujii, Hiroki Kawauchi, Yoshiaki Doi, Machiko Irie, Takuya Torizawa, Kengo Kinoshita et al. · 2026 · Redox Biology
  83. Accelerating Cosmetic Innovation Through Next-Generation Computational Toxicology: From Structural Alerts to Molecular Dynamics and Artificial Intelligence for Skin Sensitization Assessment
    Thomas Enrique Quintero-Trujillo, Liseth DÍAZ-ROJAS, Helen Andrade, Paola Alfonso-Romero · 2026 · Toxics
  84. Reactive Oxygen Species in Breast Cancer: From Redox Dysregulation to ROS‐Responsive Therapeutics
    Marija Nikolovska, Radoslav Stojchevski, Aleksandar Eftimov, Mitko I. Mladenov, Dimiter Bogdanov Avtanski, Nikola Hadzi‐Petrushev · 2026 · Cell Biochemistry and Function
  85. Cross-species bioanalytical assessment of the oxidative stress and xenobiotic metabolism modes of action for environmental water samples – A multi-layered approach to testing and modelling
    Sebastian Lungu-Mitea, Geeta Mandava, Jana Horackova, Oksana Golovko, Zuzana Toušová, David Bednář, Lutz Ahrens, Klára Hilscherová, Johan Lundqvist · 2026 · Ecotoxicology and Environmental Safety
  86. Molecular mechanisms of autologous ozonized blood transfusion: Antioxidant and anti-inflammatory effects
    Lei Chen, Shichao Yang, Yibo Dong, Chunyan Yao · 2026 · Genes & Diseases
  87. NRF2 signalling in endometriosis: A hormone-independent axis for fertility-preserving therapeutic innovation
    Shen Chen, Yun Lu, Luxuan Wang, Anli Weng, Yuxi Miao, Li Feng, Zhiqi Wang, Mingtao Xu, Xuefang Liang, Yongxia Wang · 2026 · Pharmacological Research
  88. Dual promoter architecture of NFE2L2 underlies isoform-specific translational control of NRF2
    A. Sznarkowska, Zuzanna Urban-Wójciuk, Alicja Dziadosz-Brzezińska, Maciej Cieśla, S. Kusiński, Kevork Wakimian, A. Szabelska-Beręsewicz, Elżbieta Chruściel, Ines Papak, Natalia Marek-Trzonkowska et al. · 2026 · Redox Biology
  89. α,β-Unsaturated carbonyl-based anticancer agents targeting cysteine residues
    Chuan-Huizi Chen, Nini Zhan, Hongling Xie, Yuke Zhang, Zhengxin Zhou, Xiaojuan Liu, Yangwei Liang, Xianfei Lu, Zhiqing Liu · 2026 · Biochemical Pharmacology
  90. De Novo Discovery of Cysteine-Targeted Reversible Covalent Cyclic Peptides with Prolonged Residence Time via Phage Display
    YuQian Zhang, Mengzhu Qi, Xiankai Liu, Yukun Zhou, Yanmei Wang, Xing Xiao, Yapei Wu, Wei Gao, Yang Liu, Yiwu Zheng · 2026 · Journal of the American Chemical Society
  91. Aberrant NRF2-Dependent Cytoprotection Subverts Stress Homeostasis and Promotes Tumor Progression
    Gaoqing Feng, Yuhong Yang, H. Wang, Mao Du, Qin Xia, Lei Dong · 2026 · Current Issues in Molecular Biology
  92. Cysteine-based molecular switches: a focus on KEAP1 and BACH1 in regulating the antioxidant response
    Jialin Feng, Albena T. Dinkova‐Kostova · 2026 · Archives of Toxicology
  93. Selective NRF2 target induction despite falling NFE2L2 transcription across the MASLD spectrum: implications for marginal donor grafts and KEAP1-targeted therapy
    Sally Campbell, Róisín O’Reilly, Ola Ahmed, Matt McElheron, William C. Chapman, Cliona O’Farrelly · 2026 · Free Radical Biology and Medicine
  94. BindingDB Entry 50009857: Design, Synthesis, and Initial Evaluation of Affinity-Based Small-Molecule Probes for Fluorescent Visualization and Specific Detection of Keap1.
    BindingDB · 2021 · UC San Diego
  95. BindingDB Entry 50020171: Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitors.
    BindingDB · 2024 · UC San Diego
  96. BindingDB Entry 50047995: Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions.
    BindingDB · 2018 · UC San Diego